Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U5EU
|
||||
Former ID |
DIB007053
|
||||
Drug Name |
SC-45662
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Asthma [ICD10:J45] | Discontinued in Phase 2 | [1] | ||
Company |
GD Searle & Co
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C20H32O4S
|
||||
Canonical SMILES |
c1(c(C(C)(C)C)cc(S[C@@H]([C@H](OCC(=O)O)C)C)cc1C(C)(C)C<br />)O
|
||||
CAS Number |
CAS 135133-84-5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Arachidonate 5-lipoxygenase | Target Info | Inhibitor | [2] | |
BioCyc Pathway | Aspirin-triggered lipoxin biosynthesis | ||||
Resolvin D biosynthesis | |||||
Leukotriene biosynthesis | |||||
Lipoxin biosynthesis | |||||
Aspirin triggered resolvin D biosynthesis | |||||
Aspirin triggered resolvin E biosynthesis | |||||
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Toxoplasmosis | |||||
NetPath Pathway | IL4 Signaling Pathway | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
WikiPathways | Vitamin D Receptor Pathway | ||||
Arachidonic acid metabolism | |||||
Eicosanoid Synthesis | |||||
Selenium Micronutrient Network | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001362) | ||||
REF 2 | The immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor (SC-45662). Transplantation. 1991 Dec;52(6):1053-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.